be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

(16.38) (15.75) Cost of sales of goods 81.76 78.62 68.69 78.40 (13.07) (15.99) Gross profit 22.23 21.38 18.92 21.60 (3.31) (14.89) Other income 1.32 1.27 1.07 1.22 (0.25) (18.93) Gain on exchange rate

: Baht millions) For the year ended 31 st March Consolidated financial statement Apr 2017 - Mar 2018 Apr 2016 - Mar 2017 Change % Change Revenue from sales & service 3,376.19 3,199.82 176.37 5.5% Other

from narrower DTD/DB spread. Within this quarter there was an inventory gain of THB 241 million from the increase in crude price, but there was a loss from the crude and product oil price hedging

contracts and gain from the disposal of ordinary shares in joint venture companies • EBITDA stood at THB 33mn (down 74.9% YoY) largely as a result of the increase in unrealised loss on exchange rate. EBITDA

., the subsidiary of the Company, and change in the accounting policy regarding the record of the land appraisal To: President The Stock Exchange of Thailand Attachment: Information Memorandum on the Asset

year ended % Change 2019 2018 THB Mil % THB Mil % Revenue from sales or services 1. Visual effect 53.6 27.3 57.6 33.2 -6.9 2. Animation movie 94.2 47.9 57.5 33.1 63.8 3. Game & Production 47.9 24.4 55.6

follows: (Unit : Baht million) Consolidated Results* Year 2019 Year 2018 Increase / (Decrease) % Change Revenue from sales 120.13 214.32 (94.19) -43.95% Other revenues 3.00 0.24 2.76 1,152.06% Total

discouraged by economics. Lose sales opportunities in relation to a low level of stocks due to a limited warehouse space. Other income 2.8 6.1 117.9% A gain and profit in exchange rate comparing to the same

forecast. Although short-term economic stimulation measures from the government benefited private expenditure, but could not make a positive change to the overall GDP. (Source: Bank of Thailand). Thailand’s